We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$518B
AUM Growth
+$18.2B
Cap. Flow
-$36B
Cap. Flow %
-6.94%
Top 10 Hldgs %
29.96%
Holding
15,912
New
1,749
Increased
6,361
Reduced
6,148
Closed
1,439

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.78B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$973M
3
DIS icon
Walt Disney
DIS
+$588M
4
LLY icon
Eli Lilly
LLY
+$569M
5
T icon
AT&T
T
+$529M

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Healthcare 3.08%
3 Financials 2.41%
4 Consumer Discretionary 2.33%
5 Industrials 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
601
Republic Services
RSG
$65.9B
$119M 0.02%
624,167
+169,845
+37% +$30.1M
TXN icon
602
Texas Instruments
TXN
$250B
$119M 0.02%
683,460
+282,180
+70% +$47.1M
AZN icon
603
CALL
AstraZeneca
AZN
$244B
$119M 0.02%
877,300
+281,550
+47% +$37.3M
HYG icon
604
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$119M 0.02%
1,527,928
-3,141,891
-67% -$243M
COP icon
605
ConocoPhillips
COP
$150B
$118M 0.02%
929,411
-68,765
-7% -$7.84M
REGN icon
606
CALL
Regeneron Pharmaceuticals
REGN
$83B
$118M 0.02%
122,900
-118,500
-49% -$113M
MSTR icon
607
Strategy Inc
MSTR
$38.2B
$117M 0.02%
+688,060
New +$62.7M
KKR icon
608
CALL
KKR & Co
KKR
$103B
$117M 0.02%
1,164,600
+380,300
+48% +$35M
GILD icon
609
PUT
Gilead Sciences
GILD
$171B
$117M 0.02%
1,597,100
+379,700
+31% +$29.2M
RH icon
610
PUT
RH
RH
$3.4B
$117M 0.02%
335,500
-115,900
-26% -$31.6M
ADP icon
611
CALL
Automatic Data Processing
ADP
$110B
$116M 0.02%
466,400
+70,900
+18% +$17.3M
OGN icon
612
Organon & Co
OGN
$3.6B
$116M 0.02%
6,177,010
+1,966,914
+47% +$33.8M
NBIX icon
613
Neurocrine Biosciences
NBIX
$15.3B
$116M 0.02%
841,318
+729,318
+651% +$99.6M
MLTX icon
614
MoonLake Immunotherapeutics
MLTX
$1.4B
$116M 0.02%
2,309,433
+300,773
+15% +$16.3M
DPZ icon
615
PUT
Domino's
DPZ
$11.6B
$116M 0.02%
233,300
-312,400
-57% -$136M
OIH icon
616
PUT
VanEck Oil Services ETF
OIH
$1.95B
$116M 0.02%
344,600
-61,700
-15% -$18.7M
IYR icon
617
PUT
iShares US Real Estate ETF
IYR
$4.58B
$116M 0.02%
1,288,700
-413,900
-24% -$36.6M
DUK icon
618
CALL
Duke Energy
DUK
$97.1B
$116M 0.02%
1,195,700
+157,000
+15% +$14.9M
SOFI icon
619
PUT
SoFi Technologies
SOFI
$23.8B
$115M 0.02%
15,820,500
+7,949,700
+101% +$63.1M
DKS icon
620
CALL
Dick's Sporting Goods
DKS
$18.1B
$115M 0.02%
513,600
-4,500
-0.9% -$769K
SLB icon
621
CALL
SLB Ltd
SLB
$77.3B
$115M 0.02%
2,106,800
-320,500
-13% -$16.2M
EL icon
622
CALL
Estee Lauder
EL
$31.6B
$115M 0.02%
748,400
-247,900
-25% -$35.2M
AZN icon
623
PUT
AstraZeneca
AZN
$244B
$115M 0.02%
848,700
+388,450
+84% +$51.4M
MTZ icon
624
MasTec
MTZ
$23B
$114M 0.02%
1,217,344
+439,298
+56% +$33.4M
AFRM icon
625
CALL
Affirm
AFRM
$26.2B
$113M 0.02%
3,046,100
+52,500
+2% +$2.1M

Similar funds

Ken Griffin's Q1 2024 Portfolio in Review

As of Q1 2024, Ken Griffin held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ken Griffin withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in TD Synnex worth $245M.

  • Ken Griffin's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
  • Ken Griffin added most to Hess in Q1 2024, an estimated $1.28B increase.
  • Ken Griffin's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
  • Ken Griffin fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
  • Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
  • Ken Griffin opened 1,749 new positions and closed 1,439 in Q1 2024.
  • Ken Griffin's portfolio value rose 3.6% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.